Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Rythmodan 100mg Capsules.
| Pharmaceutical Form |
|---|
|
Capsules have a green cap and yellow body and are printed in black ink with RY on one part and RL on the other. |
Capsule containing Disopyramide 100mg.
For excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Disopyramide |
Disopyramide is a myocardial depressant and has anti-cholinergic effects. It decreases membrane responsiveness, prolongs the effective refractory period (ERP) and slows automaticity in cells with augmented automaticity. |
| List of Excipients |
|---|
|
Maize starch Capsule shell: Gelatin |
Glass Bottle containing 100 capsules.
PVC Blister containing 84 capsules.
Amber glass bottle with jaycap closure containing 100 capsules.
PVC/PVdC blister strips in cardboard cartons containing 84 capsules.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Trading as: Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0607
12 February 2009
| Drug | Countries | |
|---|---|---|
| RYTHMODAN | Australia, Canada, France, Japan, Malta, New Zealand, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
